Probiotics and Post-Pullthrough Hirschsprung's Disease-Associated Enterocolitis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

September 29, 2024

Study Completion Date

September 30, 2024

Conditions

Hirschsprung DiseaseEnterocolitisHirschsprung's Disease Associated Enterocolitis

Interventions

DIETARY_SUPPLEMENT

Saccharomyces Boulardii Probiotic Supplement

• Saccharomyces boulardii (strain CNCM I-745): 250 mg per day (5 billion colony-forming units (CFU)

Trial Locations (1)

Aswan University Hospital, Aswān

All Listed Sponsors

lead

Aswan University Hospital

OTHER

NCT07098494 - Probiotics and Post-Pullthrough Hirschsprung's Disease-Associated Enterocolitis | Biotech Hunter | Biotech Hunter